1007 Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 98013

1007 Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 98013

Saved in:
Bibliographic Details
Published in:European urology supplements : official journal of the European Association of Urology Vol. 13; no. 1; pp. e1007 - e1007a
Main Authors: Martínez-Piñeiro, L, Hernández, R, Portillo, J.A, Fernández, J.M, Zabala, J.A, Cadierno, I, Moyano, J.L, Solsona, E, Unda, M, Rodríguez-Molina, J, Beardo, P, Palou, J, Muntañola, P, Pérez-Garcia, F.J, Silva, J.M, Chesa, N, Montesinos, M, Ojea, A
Format: Journal Article
Language:English
Published: Elsevier B.V 01-04-2014
Subjects:
Urology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1569-9056
1878-1500
DOI:10.1016/S1569-9056(14)60990-8